Liver Enzymes are Associated with Hyperglycemia in Diabetes: A Three-Year Retrospective Study

References

• Zimmet PZ, Magliano DJ, Herman WH, et al. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56–64. doi:10.1016/s2213-8587(13)70112-8
   PubMed Web of Science ®Google Scholar
• Han HS, Kang G, Kim JS, et al. Regulation of glucose metabolism from a liver-centric perspective. Exp Mol Med. 2016;48:e218. doi:10.1038/emm.2015.122
   PubMed Web of Science ®Google Scholar
• Rantala AO, Lilja M, Kauma H, et al. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248(3):230–238. doi:10.1046/j.1365-2796.2000.00723.x
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey TA, Walley J. Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. Am J Epidemiol. 2013;178(2):159–171. doi:10.1093/aje/kws469
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Lennon L, et al. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care. 2005;28(12):2913–2918. doi:10.2337/diacare.28.12.2913
   PubMed Web of Science ®Google Scholar
• Doi Y, Kubo M, Yonemoto K, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity. 2007;15(7):1841–1850. doi:10.1038/oby.2007.218
   Web of Science ®Google Scholar
• Lee DH, Ha MH, Kim JH, et al. Gamma-glutamyltransferase and diabetes–a 4 year follow-up study. Diabetologia. 2003;46(3):359–364. doi:10.1007/s00125-003-1036-5
   Web of Science ®Google Scholar
• Xu L, Jiang CQ, Lam TH, et al. Mendelian randomization estimates of alanine aminotransferase with cardiovascular disease: Guangzhou Biobank Cohort study. Hum Mol Genet. 2017;26(2):430–437. doi:10.1093/hmg/ddw396
   Web of Science ®Google Scholar
• Lu J, He J, Li M, et al. Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults. Diabetes Care. 2019;42(8):1539–1548. doi:10.2337/dc18-1390
   PubMed Web of Science ®Google Scholar
• Pulzi FB, Cisternas R, Melo MR, et al. New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol Metab Syndr. 2011;3(1):3. doi:10.1186/1758-5996-3-3
   Web of Science ®Google Scholar
• Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–854. doi:10.1002/hep.21496
   PubMed Web of Science ®Google Scholar
• Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. doi:10.1186/1471-230X-6-33
   PubMed Web of Science ®Google Scholar
• Ekberg K, Landau BR, Wajngot A, et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 1999;48(2):292–298. doi:10.2337/diabetes.48.2.292
   PubMed Web of Science ®Google Scholar
• Moore MC, Coate KC, Winnick JJ, et al. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr. 2012;3(3):286–294. doi:10.3945/an.112.002089
   PubMed Web of Science ®Google Scholar
• De Silva NMG, Borges MC, Hingorani AD, et al. Liver function and risk of type 2 diabetes: bidirectional Mendelian randomization study. Diabetes. 2019;68(8):1681–1691. doi:10.2337/db18-1048
   PubMed Web of Science ®Google Scholar
• Lee YS, Cho Y, Burgess S, et al. Serum gamma-glutamyl transferase and risk of type 2 diabetes in the general Korean population: a Mendelian randomization study. Hum Mol Genet. 2016;25(17):3877–3886. doi:10.1093/hmg/ddw226
   Web of Science ®Google Scholar
• Noordam R, Smit RA, Postmus I, et al. Assessment of causality between serum gamma-glutamyltransferase and type 2 diabetes mellitus using publicly available data: a Mendelian randomization study. Int J Epidemiol. 2016;45(6):1953–1960. doi:10.1093/ije/dyw306
   Web of Science ®Google Scholar
• Liu J, Au Yeung SL, Lin SL, et al. Liver enzymes and risk of ischemic heart disease and type 2 diabetes mellitus: a Mendelian randomization study. Sci Rep. 2016;6:38813. doi:10.1038/srep38813
   Web of Science ®Google Scholar
• Ballestri S, Zona S, Targher G, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936–944. doi:10.1111/jgh.13264
   PubMed Web of Science ®Google Scholar
• Karp DR, Shimooku K, Lipsky PE. Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem. 2001;276(6):3798–3804. doi:10.1074/jbc.M008484200
   PubMed Web of Science ®Google Scholar
• André P, Balkau B, Born C, et al. Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. the D.E.S.I.R. study (data from an epidemiological study on the insulin resistance syndrome). Diabetes Metab. 2005;31(6):542–550. doi:10.1016/S1262-3636(07)70229-X
   Web of Science ®Google Scholar
• Muriach M, Flores-Bellver M, Romero FJ, et al. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev. 2014;2014:102158. doi:10.1155/2014/102158
   PubMed Web of Science ®Google Scholar
• Drozdz R, Parmentier C, Hachad H, et al. γ-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med. 1998;25(7):786–792. doi:10.1016/S0891-5849(98)00127-0
   Web of Science ®Google Scholar
• Hanigan MH, Frierson HF. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem. 1996;44(10):1101–1108. doi:10.1177/44.10.8813074
   Web of Science ®Google Scholar
• Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem. 2014;29(3):269–278. doi:10.1007/s12291-013-0408-y
   PubMedGoogle Scholar
• Lynes M, Narisawa S, Millán JL, et al. Interactions between CD36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet. Am J Physiol Regul Integr Comp Physiol. 2011;301(6):R1738–R1747. doi:10.1152/ajpregu.00235.2011
   Web of Science ®Google Scholar
• Eduard AS. Phosphatase high-throughput screening assay design and selection. In: Millán JL, editor. Phosphatase Modulators. Berlin: Springer; 2013:18–42.
   Google Scholar
• Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab. 2009;296(4):E581–E591. doi:10.1152/ajpendo.90437.2008
   PubMed Web of Science ®Google Scholar
• Oh SW, Han KH, Han SY. Associations between renal hyperfiltration and serum alkaline phosphatase. PLoS One. 2015;10(4):e0122921. doi:10.1371/journal.pone.0122921
   Web of Science ®Google Scholar